6^th World Congress on Virology and Diseases Control November 20-21, 2023 London, UK

Track 01: General Virology

The study of viruses' biology, including their distribution, biochemistry, physiology, molecular biology, ecology, evolution, and clinical aspects, is the subject of the scientific field of virology. A sickness that decimates our bee population and endangers natural pollination cycles and hence much of agriculture has been linked to viruses. The taxonomy of viruses is a key area of virology. Animal, plant, fungal, and bacteriophage viruses, as well as other types of viruses, can all be classed according to the host cell they infect. Colds, influenza, rabies, measles, various types of diarrhea, hepatitis, dengue, yellow fever, polio, smallpox, and AIDS are just a few of the serious infectious diseases that are caused by viruses.

Track 02: Corona Virus (Covid 19)

A recently identified coronavirus (COVID-19) is the infectious disease known as novel coronavirus disease. Coronaviruses in humans produce respiratory tract infections that can range in severity from minor (common cold) to lethal (SARS, MERS, and COVID-19), recover without the need for special care, and can also cause a number of diseases in birds and mammals. Serious illness is more likely to affect the elderly and those with medical disorders such diabetes, chronic respiratory diseases, cardiovascular diseases, and cancer. The sickness brought on by a new coronavirus is now without a specific treatment.

Track 03: Viral Immunology

Simply put, the study of immunological reactions to viruses is known as viral immunology. Immunopathology is the study of immunological responses to viruses that cause tissue damage over a lengthy period of time. These conditions most frequently include persistent infections, which in the absence of an immune response are frequently modestly cytodestructive. Virus-induced chronic tissue damage can potentially result in the emergence of an autonomic, and occasionally carcinogenic response.

Track 04: Viral Vaccines

Two of the most effective vaccines in the world are those against smallpox and poliovirus. Vaccines are one of the healthiest ways to protect a person from viral disease. Activated and inactivated viruses are both used in viral vaccinations. Viral vaccines that have been inactivated or destroyed still contain viruses, but they are unable to multiply or elicit a reaction if they also contain an antigen. Vaccines that are activated or "live" include the virus in its alive state. A novel concept of vaccine is now being organized using virus-like particles.

Track 05: Anti-Retroviral Therapy

Antiretroviral therapy is a term used to describe HIV treatment that combines two or more antiretroviral medications. Since its invention in 1996, antiretroviral therapy has revolutionized the management of HIV. Antiretroviral therapy is a successful HIV treatment. The viral load can be reduced to undetectable levels, but it does not cure the illness. This implies that the virus cannot be spread through sexual activity and that the immune system of a person can be rebuilt. The viral load typically takes between three and six months to become undetectable.

Track 06: Pediatric Viral Infectious Diseases

Viral infections are a common occurrence in childhood and adolescence. Clinicians frequently treat infections in children and adolescents brought on by a variety of viral viruses. These infections appear in a variety of ways. Depending on the patient's age and immunocompetence, many illnesses might appear clinically in a way that is unique to the virus that is causing them. When a maternal illness causes an infection in utero (such as cytomegalovirus, rubella virus, or parvovirus B19), some children are negatively impacted early in life. Other viruses, such as rhinoviruses or influenza viruses can infect children in a predictable fashion as they age.

Track 07: Antiviral Drug Discovery and Development

Viruses, intracellular infections, have historically affected human health because they have evolved numerous cunning techniques to elude host immune responses. It is a never-ending challenge to combat viral illnesses using vaccinations, antivirals, or both. The fast pace of genetic change demonstrated by many viruses, especially RNA viruses, often causes treatment resistance or vaccination escape even when successful tactics are discovered and applied. The recurring appearance of novel viral infections exacerbates this.

Track 08: Plant and Agricultural Virology

The cyclical spread of viral infections within plant populations through time and location is the focus of plant viral disease epidemiology. Positive-sense single-stranded RNA viruses, such as the tobacco mosaic virus (TMV), infect a wide range of plants, most notably tobacco and other plants in the nightshade family. Viral entry, which occurs when the virus invades the host cell and releases viral material into the cell, is the first stage of viral infection.

Track 09: Viral Oncology

Viral oncology is a branch of oncology that deals with using viral particles to treat human malignancies and tumors. Approximately 20% of malignancies worldwide are caused by chronic infections; in particular, up to 15% of human cancers have a viral etiology and are more common in underdeveloped nations. There is no doubt that some tumors contagious nature has significant consequences for their prevention, diagnosis, and therapy. With important and novel new investigations on viral oncogenesis and translational research from virology for the treatment of cancer, viral oncology research is still active in the twenty-first century.

Track 10: STD & HIV/ AIDS and Emerging Viral Diseases

An infection with HIV and AIDS is brought on by the human immunodeficiency virus. Your blood or saliva is tested for antibodies to the virus in order to diagnose HIV. Clinical trials for HIV/AIDS are research projects carried out to better understand, identify, or treat the disease. The main method for establishing whether novel medical treatments for HIV/AIDS are secure and efficient in people is through clinical trials.

Track 11: Hepatic viral diseases      

Hepatitis refers to liver inflammation. The liver may become inflamed for a variety of reasons, including autoimmune illnesses, medications, alcohol, chemicals, and environmental toxins. The liver can become inflamed by a variety of viruses, including the cytomegalovirus and the mononucleosis virus. The liver is only one of the many organs that viruses damage; most viruses do not target it specifically. Hepatitis virus types A, B, C, D, E, F (unconfirmed), and G are among the many that exist. Types A, B, and C of hepatitis viruses are the most prevalent. Hepatitis viruses are frequently mentioned in abbreviated form; for instance, the abbreviations HAV, HBV, and HCV stand for the hepatitis A, B, and C viruses, respectively.

Track 12: Neurologic viral diseases

The most significant field that shows how clinical neurology, virology, immunology, and molecular biology are connected is neurological viral disorders. The investigation of viruses that can harm the neurological system is the primary goal of this discipline. Without it, there would be no need for gene therapy, additional research into this division, or the ability to map out neuroanatomical pathways using specific viruses.

Track 13: Respiratory viral diseases

Respiratory tract infections are currently among the most prevalent viral infections. Infections of the sinuses, throat, respiratory system, or lungs are all considered respiratory tract infections. Upper respiratory tract infections (URTI) and Lower respiratory tract infections (LRTI) are the two sub-divisions of respiratory tract infections (ITR). Adenovirus, Para influenza virus, respiratory syncytial virus, coronavirus, coxsackie virus, and human metapneumovirus are the viruses linked to respiratory illnesses.

Track 14: Gastrointestinal viral diseases

The symptoms of viral gastroenteritis, an infection of the intestines, include watery diarrhoea, cramping in the abdomen, nausea or vomiting, and occasionally fever.  If you are otherwise healthy, you should be able to recover quickly. Viral gastroenteritis, however, has the potential to be lethal in infants, the elderly, and those with compromised immune systems. Viral gastroenteritis has no proven effective treatment, so prevention is key. Your best line of defence includes avoiding potentially contaminated food and water, as well as washing your hands thoroughly and frequently.

Track 15: Molecular and Cellular Virology

A branch of evolutionary biology and virology called viral evolution is devoted to studying the evolution of viruses. Numerous viruses, particularly RNA viruses, have quick generation times and generally high mutation rates (RNA viruses often have one or more point mutations per genome per replication cycle). Virus genomes are extraordinarily varied, tiny, and prone to rapid genetic mutation.

Track 16: Animal Virology

Viruses are single-celled microorganisms that are smaller, simpler, and only contain one form of nucleic acid, either DNA or RNA, never both. Since viruses lack ribosomes, mitochondria, or any other organelles, they are totally reliant on their cellular hosts for the synthesis of proteins and the production of energy. They only carry out their replication within the host's cells. The necessity to control viral illnesses in humans and their pets has contributed significantly to the development of animal virology. Like other contagious substances, viruses enter an animal's body through one of its surfaces. To cause a systemic infection, they subsequently spread locally on one of the body's surfaces or through lymphatic and blood arteries.

Track 17: Clinical and Diagnostic Virology

Identification of the culpable virus by a number of procedures, including specialized, general, or traditional assays, to make a diagnosis of any possible viral infection. Serology, viral culture, antigen detection, and nucleic acid detection are just a few of the techniques used in laboratory diagnosis to look for viral infections. We see that sophisticated and rather outstanding immunological and molecular diagnostic tests are being developed as a result of numerous technology advancements to deliver more precise results, to detect the kind and amount of viruses as well as to assess their pathogenicity. For the diagnostic strategy of viral infections that are clinically significant, this field offers detailed suggestions.

Market Analysis: 6th World Congress on Virology and Diseases Control (Virology Diseases-2023)

The global landscape of virology and diseases control is undergoing remarkable transformations, fueled by groundbreaking research, technological innovations, and a heightened awareness of the critical role played by viruses in human and animal health. The Virology Diseases-2023 provides an opportune platform to delve into the market dynamics, trends, and opportunities within this rapidly evolving field.

Market Insights:

The field of virology has witnessed significant growth in recent years due to the increasing prevalence of viral infections, emerging diseases, and a growing understanding of the molecular mechanisms underlying viral pathogenesis. This has led to a surge in research activities focused on the development of innovative diagnostic tools, therapeutic strategies, and preventive measures.

The market for virology and diseases control encompasses a wide range of sectors, including diagnostics, pharmaceuticals, biotechnology, research tools, and more. Key market trends include:

• Diagnostic Innovations: Advancements in molecular diagnostics, such as polymerase chain reaction (PCR) techniques and next-generation sequencing, have revolutionized the identification and characterization of viral infections, enabling rapid and accurate diagnosis.
• Vaccines and Therapeutics: The demand for effective antiviral therapies and vaccines has spurred research and development efforts to combat both established and emerging viral diseases. Novel treatment modalities and vaccine technologies are gaining traction.
• Public Health Preparedness: The global impact of pandemics like COVID-19 has highlighted the critical need for robust public health infrastructure, surveillance systems, and rapid response mechanisms to contain viral outbreaks.
• Emerging Viral Diseases: With the continuous emergence of novel viruses, the market for diagnostics, therapeutics, and vaccines targeting these new threats is expanding rapidly.
• Collaborative Research: Collaborations between academia, industry, and research institutions are fostering cross-disciplinary approaches to tackle virological challenges, driving research and product development.

Opportunities:

• Diagnostics: The demand for accurate and rapid viral diagnostic solutions is growing, presenting opportunities for innovative point-of-care testing devices and platforms.
• Vaccine Development: The increasing focus on preventive measures against viral diseases has opened avenues for the development of novel vaccines, including mRNA-based platforms.
• Antiviral Therapies: The pursuit of targeted antiviral therapies with reduced side effects and improved efficacy offers a promising market segment.
• Bioinformatics and Data Analytics: As virology generates vast amounts of data, the integration of bioinformatics and data analytics is crucial for understanding viral dynamics and designing effective interventions.
• Investment and Funding: The growing interest in virology research is attracting investments from both private and public sectors, driving innovation and product development.

Conclusion:

The Virology Diseases-2023 serves as a platform to explore the current trends, challenges, and market opportunities in virology and diseases control. By bringing together researchers, industry professionals, and experts from around the world, the conference aims to facilitate discussions, collaborations, and insights that will contribute to the advancement of virology research, healthcare solutions, and disease control strategies. Join us to be part of the global conversation shaping the future of virology and diseases control.